abstract |
The present invention relates to compounds which are inhibitors of phosphodiesterase-4 (PDE4) useful for the treatment and prevention of stroke, myocardial infarct, cardiovascular inflammatory diseases and disorders and central nervous system disorders, to compounds with a selectivity for a non-catalytic portion of PDE4, to methods of determining this selectivity. |